Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CD45 Positive Control | Login | CD45 Positive Control | ||||||||||||||||
|
||||||||||||||||||
KMT6 / EZH2 Positive Control | Login | KMT6 / EZH2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
FLT3 / CD135 Positive Control | Login | FLT3 / CD135 Positive Control | ||||||||||||||||
|
||||||||||||||||||
IRAKM Positive Control | Login | IRAKM Positive Control | ||||||||||||||||
|
||||||||||||||||||
RBP2 Positive Control | Login | RBP2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
CD134 / OX40L receptor Positive Control | Login | CD134 / OX40L receptor Positive Control | ||||||||||||||||
|
||||||||||||||||||
IRAKM Antibody | Login | IRAKM Antibody | ||||||||||||||||
|
||||||||||||||||||
IRAKM Antibody BIOTIN | Login | IRAKM Antibody BIOTIN | ||||||||||||||||
|
||||||||||||||||||
IRAKM Antibody FITC | Login | IRAKM Antibody FITC | ||||||||||||||||
|
||||||||||||||||||
KDM4C / GASC1 / JMJD2C Antibody | Login | KDM4C / GASC1 / JMJD2C Antibody | ||||||||||||||||
|
||||||||||||||||||
OTOP2 Antibody | Login | OTOP2 Antibody | ||||||||||||||||
|
||||||||||||||||||
OTOP2 Antibody BIOTIN | Login | OTOP2 Antibody BIOTIN | ||||||||||||||||
|
||||||||||||||||||
OTOP2 Antibody FITC | Login | OTOP2 Antibody FITC | ||||||||||||||||
|
||||||||||||||||||
AMPK alpha 1 Blocking Peptide | Login | AMPK alpha 1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
AMPK alpha 2 Blocking Peptide | Login | AMPK alpha 2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
OTOP2 Blocking Peptide | Login | OTOP2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Wilms Tumor Protein Blocking Peptide | Login | Wilms Tumor Protein Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
AMPK alpha 1 Positive Control | Login | AMPK alpha 1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
AMPK alpha 2 Positive Control | Login | AMPK alpha 2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
OTOP2 Positive Control | Login | OTOP2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Wilms Tumor Protein Positive Control | Login | Wilms Tumor Protein Positive Control | ||||||||||||||||
|
||||||||||||||||||
RBP2 Antibody BIOTIN | Login | RBP2 Antibody BIOTIN | ||||||||||||||||
|
||||||||||||||||||
RBP2 Antibody FITC | Login | RBP2 Antibody FITC | ||||||||||||||||
|
||||||||||||||||||
CD134 / OX40L receptor Antibody BIOTIN | Login | CD134 / OX40L receptor Antibody BIOTIN | ||||||||||||||||
|
||||||||||||||||||
CD134 / OX40L receptor Antibody FITC | Login | CD134 / OX40L receptor Antibody FITC | ||||||||||||||||
|